Foreign media: Chinese scientists have made a breakthrough in treating type 1 diabetes, successfully developing a stem cell therapy using the patient's own cells. A 25-year-old woman stopped relying on insulin after treatment, regained her ability to secrete insulin, had stable blood sugar levels, and did not need insulin injections for more than a year.
This research, led by a research team from Peking University, used chemical-induced pluripotent stem cell (CiPSC) technology to reprogram patients' adult cells into pancreatic beta cells, which were then formed into three-dimensional islet clusters and transplanted into the abdominal muscle for easy monitoring. The therapy avoided the risks of genetic modification and immune rejection, but due to the patient previously taking immunosuppressants, further verification is needed to evaluate its effectiveness without immunosuppression.
Although this therapy is still in its early stages, long-term safety and scalability need to be considered. However, it brings new hope for curing diabetes and may change the landscape of chronic disease treatment.
Original source: www.toutiao.com/article/1840145437379656/
Statement: This article represents the views of the author.